{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:50:42Z","timestamp":1794610242211,"version":"4.9.1"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41574-025-01203-y","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:37:23Z","timestamp":1763393843000},"page":"228-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Kidney diseases and the thyroid: interactions and consequences"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-7652","authenticated-orcid":false,"given":"Gabriela","family":"Brenta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"1203_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"1203_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03466-5","volume":"25","author":"DR Farrell","year":"2024","unstructured":"Farrell, D. R. & Vassalotti, J. A. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC Nephrol. 25, 34 (2024).","journal-title":"BMC Nephrol."},{"key":"1203_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","volume":"99","author":"MG Shlipak","year":"2021","unstructured":"Shlipak, M. G. et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 99, 34\u201347 (2021).","journal-title":"Kidney Int."},{"key":"1203_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin, A. et al. Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns. Kidney Int. 105, 684\u2013701 (2024).","journal-title":"Kidney Int."},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11154-016-9395-7","volume":"18","author":"P Iglesias","year":"2017","unstructured":"Iglesias, P., Bajo, M. A., Selgas, R. & Diez, J. J. Thyroid dysfunction and kidney disease: an update. Rev. Endocr. Metab. Disord. 18, 131\u2013144 (2017). This review covers all the mechanistic pathways of the mutual relationship between the thyroid and the kidney and clearly describes how thyroid hormones influence renal development, kidney haemodynamics, GFR and sodium and water homeostasis. It also shows that most renal manifestations of thyroid dysfunction are reversible with treatment.","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10157-014-0974-1","volume":"18","author":"G Xu","year":"2014","unstructured":"Xu, G., Yan, W. & Li, J. An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases. Clin. Exp. Nephrol. 18, 837\u2013843 (2014).","journal-title":"Clin. Exp. Nephrol."},{"key":"1203_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2293224","volume":"45","author":"R Yuasa","year":"2023","unstructured":"Yuasa, R. et al. Urinary excretion of thyroid hormone in CKD patients: a proof-of-concept of nephrogenic hypothyroidism. Ren. Fail. 45, 2293224 (2023).","journal-title":"Ren. Fail."},{"key":"1203_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/thy.2019.0167","volume":"30","author":"C Ellervik","year":"2020","unstructured":"Ellervik, C., Mora, S., Ridker, P. M. & Chasman, D. I. Hypothyroidism and kidney function: a Mendelian randomization study. Thyroid 30, 365\u2013379 (2020).","journal-title":"Thyroid"},{"key":"1203_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpeds.2008.08.023","volume":"154","author":"J Kumar","year":"2009","unstructured":"Kumar, J., Gordillo, R., Kaskel, F. J., Druschel, C. M. & Woroniecki, R. P. Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism. J. Pediatr. 154, 263\u2013266 (2009).","journal-title":"J. Pediatr."},{"key":"1203_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.ASN.0000053417.33945.63","volume":"14","author":"MA Cadnapaphornchai","year":"2003","unstructured":"Cadnapaphornchai, M. A. et al. Urinary concentrating defect in hypothyroid rats: role of sodium, potassium, 2-chloride co-transporter, and aquaporins. J. Am. Soc. Nephrol. 14, 566\u2013574 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1203_CR11","doi-asserted-by":"publisher","first-page":"F1097","DOI":"10.1152\/ajprenal.00368.2002","volume":"284","author":"R Schmitt","year":"2003","unstructured":"Schmitt, R., Klussmann, E., Kahl, T., Ellison, D. H. & Bachmann, S. Renal expression of sodium transporters and aquaporin-2 in hypothyroid rats. Am. J. Physiol. Ren. Physiol. 284, F1097\u2013F1104 (2003). This study shows how hypothyroidism is associated with abnormalities in the renal handling of salt and water. Rats rendered pharmacologically hypothyroid show a marked reduction in kidney size and creatinine clearance along with decreased NHE3 and NPT2A in the\u00a0proximal tubule.","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1113\/jphysiol.1995.sp020979","volume":"488","author":"S Euzet","year":"1995","unstructured":"Euzet, S., Lelievre-Pegorier, M. & Merlet-Benichou, C. Maturation of rat renal phosphate transport: effect of triiodothyronine. J. Physiol. 488, 449\u2013457 (1995).","journal-title":"J. Physiol."},{"key":"1203_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1046\/j.1523-1755.1998.00879.x","volume":"53","author":"M Baum","year":"1998","unstructured":"Baum, M., Dwarakanath, V., Alpern, R. J. & Moe, O. W. Effects of thyroid hormone on the neonatal renal cortical Na+\/H+ antiporter. Kidney Int. 53, 1254\u20131258 (1998).","journal-title":"Kidney Int."},{"key":"1203_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000013593","volume":"20","author":"F Nakhoul","year":"2000","unstructured":"Nakhoul, F., Thompson, C. B. & McDonough, A. A. Developmental change in Na,K-ATPase \u03b11 and \u03b21 expression in normal and hypothyroid rat renal cortex. Am. J. Nephrol. 20, 225\u2013231 (2000).","journal-title":"Am. J. Nephrol."},{"key":"1203_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-physiol-042222-024724","volume":"86","author":"M Chrysopoulou","year":"2024","unstructured":"Chrysopoulou, M. & Rinschen, M. M. Metabolic rewiring and communication: an integrative view of kidney proximal tubule function. Annu. Rev. Physiol. 86, 405\u2013427 (2024).","journal-title":"Annu. Rev. Physiol."},{"key":"1203_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1681\/ASN.2010070766","volume":"23","author":"LH Mariani","year":"2012","unstructured":"Mariani, L. H. & Berns, J. S. The renal manifestations of thyroid disease. J. Am. Soc. Nephrol. 23, 22\u201326 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1203_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/2230-8210.93737","volume":"16","author":"G Basu","year":"2012","unstructured":"Basu, G. & Mohapatra, A. Interactions between thyroid disorders and kidney disease. Indian J. Endocrinol. Metab. 16, 204\u2013213 (2012).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"1203_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/JOE-11-0349","volume":"213","author":"F Vargas","year":"2012","unstructured":"Vargas, F., Rodriguez-Gomez, I., Vargas-Tendero, P., Jimenez, E. & Montiel, M. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J. Endocrinol. 213, 25\u201336 (2012).","journal-title":"J. Endocrinol."},{"key":"1203_CR19","first-page":"E227","volume":"272","author":"H Kobori","year":"1997","unstructured":"Kobori, H. et al. Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. Am. J. Physiol. 272, E227\u2013E232 (1997).","journal-title":"Am. J. Physiol."},{"key":"1203_CR20","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1001\/jama.1983.03340180043023","volume":"250","author":"RC Smallridge","year":"1983","unstructured":"Smallridge, R. C., Rogers, J. & Verma, P. S. Serum angiotensin-converting enzyme. Alterations in hyperthyroidism, hypothyroidism, and subacute thyroiditis. JAMA 250, 2489\u20132493 (1983).","journal-title":"JAMA"},{"key":"1203_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein, I. & Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501\u2013509 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1203_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semnephrol.2021.03.008","volume":"41","author":"Y Narasaki","year":"2021","unstructured":"Narasaki, Y., Sohn, P. & Rhee, C. M. The interplay between thyroid dysfunction and kidney disease. Semin. Nephrol. 41, 133\u2013143 (2021).","journal-title":"Semin. Nephrol."},{"key":"1203_CR23","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","volume":"71","author":"S Razvi","year":"2018","unstructured":"Razvi, S. et al. Thyroid hormones and cardiovascular function and diseases. J. Am. Coll. Cardiol. 71, 1781\u20131796 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1203_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0026-0495(72)90052-2","volume":"21","author":"DC Evered","year":"1972","unstructured":"Evered, D. C., Hayter, C. J. & Surveyor, I. Primary polydipsia in thyrotoxicosis. Metabolism 21, 393\u2013404 (1972).","journal-title":"Metabolism"},{"key":"1203_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/vr.131.12.257","volume":"131","author":"KL Thoday","year":"1992","unstructured":"Thoday, K. L. & Mooney, C. T. Historical, clinical and laboratory features of 126 hyperthyroid cats. Vet. Rec. 131, 257\u2013264 (1992).","journal-title":"Vet. Rec."},{"key":"1203_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/sj.ki.5002475","volume":"72","author":"W Wang","year":"2007","unstructured":"Wang, W., Li, C., Summer, S. N., Falk, S. & Schrier, R. W. Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int. 72, 1088\u20131094 (2007).","journal-title":"Kidney Int."},{"key":"1203_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3803\/EnM.2021.1333","volume":"37","author":"YY Cho","year":"2022","unstructured":"Cho, Y. Y. et al. Graves\u2019 disease and the risk of end-stage renal disease: a Korean population-based study. Endocrinol. Metab. 37, 281\u2013289 (2022).","journal-title":"Endocrinol. Metab."},{"key":"1203_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9629(15)40631-7","volume":"318","author":"C Villabona","year":"1999","unstructured":"Villabona, C. et al. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am. J. Med. Sci. 318, 277\u2013280 (1999).","journal-title":"Am. J. Med. Sci."},{"key":"1203_CR29","doi-asserted-by":"publisher","first-page":"F672","DOI":"10.1152\/ajprenal.00384.2004","volume":"289","author":"YC Chen","year":"2005","unstructured":"Chen, Y. C. et al. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. Am. J. Physiol. Ren. Physiol. 289, F672\u2013F678 (2005).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1203_CR30","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1172\/JCI106336","volume":"49","author":"EW Holmes Jr.","year":"1970","unstructured":"Holmes, E. W. Jr. & DiScala, V. A. Studies on the exaggerated natriuretic response to a saline infusion in the hypothyroid rat. J. Clin. Invest. 49, 1224\u20131236 (1970).","journal-title":"J. Clin. Invest."},{"key":"1203_CR31","doi-asserted-by":"publisher","first-page":"14308","DOI":"10.1016\/S0021-9258(18)77301-8","volume":"265","author":"B Horowitz","year":"1990","unstructured":"Horowitz, B. et al. Differential regulation of Na,K-ATPase 1, \u03b12, and \u03b2 subunit mRNA and protein levels by thyroid hormone. J. Biol. Chem. 265, 14308\u201314314 (1990).","journal-title":"J. Biol. Chem."},{"key":"1203_CR32","first-page":"735","volume":"35","author":"JM Moreno","year":"2012","unstructured":"Moreno, J. M. et al. Function and expression of renal epithelial sodium transporters in rats with thyroid dysfunction. J. Endocrinol. Invest. 35, 735\u2013741 (2012).","journal-title":"J. Endocrinol. Invest."},{"key":"1203_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/ijao.5000300","volume":"37","author":"P Dousdampanis","year":"2014","unstructured":"Dousdampanis, P., Trigka, K., Vagenakis, G. A. & Fourtounas, C. The thyroid and the kidney: a complex interplay in health and disease. Int. J. Artif. Organs 37, 1\u201312 (2014).","journal-title":"Int. J. Artif. Organs"},{"key":"1203_CR34","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/321030","volume":"2011","author":"M Franco","year":"2011","unstructured":"Franco, M., Chavez, E. & Perez-Mendez, O. Pleiotropic effects of thyroid hormones: learning from hypothyroidism. J. Thyroid. Res. 2011, 321030 (2011).","journal-title":"J. Thyroid. Res."},{"key":"1203_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13050813","volume":"13","author":"R Di Paola","year":"2023","unstructured":"Di Paola, R. et al. Impact of thyroid cancer treatment on renal function: a relevant issue to be addressed. J. Pers. Med. 13, 813 (2023).","journal-title":"J. Pers. Med."},{"key":"1203_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/thy.2013.0110","volume":"24","author":"SK Kim","year":"2014","unstructured":"Kim, S. K. et al. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer. Thyroid 24, 773\u2013777 (2014).","journal-title":"Thyroid"},{"key":"1203_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006004","volume":"96","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients. Medicine 96, e6004 (2017).","journal-title":"Medicine"},{"key":"1203_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ndt\/gfu303","volume":"30","author":"CM Rhee","year":"2015","unstructured":"Rhee, C. M. et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol. Dial. Transpl. 30, 282\u2013287 (2015).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1203_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0272-6386(96)90539-9","volume":"27","author":"J Montenegro","year":"1996","unstructured":"Montenegro, J. et al. Changes in renal function in primary hypothyroidism. Am. J. Kidney Dis. 27, 195\u2013198 (1996).","journal-title":"Am. J. Kidney Dis."},{"key":"1203_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archinte.159.1.79","volume":"159","author":"SH Kreisman","year":"1999","unstructured":"Kreisman, S. H. & Hennessey, J. V. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch. Intern. Med. 159, 79\u201382 (1999).","journal-title":"Arch. Intern. Med."},{"key":"1203_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1440-1797.2003.00144.x","volume":"8","author":"A Mooraki","year":"2003","unstructured":"Mooraki, A., Broumand, B., Neekdoost, F., Amirmokri, P. & Bastani, B. Reversible acute renal failure associated with hypothyroidism: report of four cases with a brief review of literature. Nephrology 8, 57\u201360 (2003).","journal-title":"Nephrology"},{"key":"1203_CR42","first-page":"440","volume":"1","author":"A Connor","year":"2008","unstructured":"Connor, A. & Taylor, J. E. Renal impairment resulting from hypothyroidism. NDT Plus 1, 440\u2013441 (2008).","journal-title":"NDT Plus"},{"key":"1203_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-2265.2005.02236.x","volume":"62","author":"JG den Hollander","year":"2005","unstructured":"den Hollander, J. G., Wulkan, R. W., Mantel, M. J. & Berghout, A. Correlation between severity of thyroid dysfunction and renal function. Clin. Endocrinol. 62, 423\u2013427 (2005).","journal-title":"Clin. Endocrinol."},{"key":"1203_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10157-012-0727-y","volume":"17","author":"Y Hataya","year":"2013","unstructured":"Hataya, Y., Igarashi, S., Yamashita, T. & Komatsu, Y. Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients. Clin. Exp. Nephrol. 17, 525\u2013531 (2013). In this retrospective study of 51 Japanese patients with primary hypothyroidism who received levothyroxine therapy, patients with lower eGFR values at baseline show the most significant improvement, and eGFR increases by about 30% in patients with CKD, showing that prompt diagnosis of hypothyroidism in patients with previous renal disease should always be considered.","journal-title":"Clin. Exp. Nephrol."},{"key":"1203_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000075628","volume":"24","author":"G Karanikas","year":"2004","unstructured":"Karanikas, G. et al. Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am. J. Nephrol. 24, 41\u201345 (2004).","journal-title":"Am. J. Nephrol."},{"key":"1203_CR46","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/thy.2015.0173","volume":"25","author":"GB Coura-Filho","year":"2015","unstructured":"Coura-Filho, G. B., Willegaignon, J., Buchpiguel, C. A. & Sapienza, M. T. Effects of thyroid hormone withdrawal and recombinant human thyrotropin on glomerular filtration rate during radioiodine therapy for well-differentiated thyroid cancer. Thyroid 25, 1291\u20131296 (2015).","journal-title":"Thyroid"},{"key":"1203_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00511","volume":"9","author":"LH Duntas","year":"2018","unstructured":"Duntas, L. H. & Brenta, G. A renewed focus on the association between thyroid hormones and lipid metabolism. Front. Endocrinol. 9, 511 (2018).","journal-title":"Front. Endocrinol."},{"key":"1203_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11906-003-0060-7","volume":"5","author":"S Danzi","year":"2003","unstructured":"Danzi, S. & Klein, I. Thyroid hormone and blood pressure regulation. Curr. Hypertens. Rep. 5, 513\u2013520 (2003).","journal-title":"Curr. Hypertens. Rep."},{"key":"1203_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1106968","volume":"14","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. Subclinical hypothyroidism increases insulin resistance in normoglycemic people. Front. Endocrinol. 14, 1106968 (2023).","journal-title":"Front. Endocrinol."},{"key":"1203_CR50","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","volume":"304","author":"N Rodondi","year":"2010","unstructured":"Rodondi, N. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365\u20131374 (2010).","journal-title":"JAMA"},{"key":"1203_CR51","doi-asserted-by":"publisher","first-page":"l2006","DOI":"10.1136\/bmj.l2006","volume":"365","author":"GE Bekkering","year":"2019","unstructured":"Bekkering, G. E. et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ 365, l2006 (2019).","journal-title":"BMJ"},{"key":"1203_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1590\/S0004-27302013000400003","volume":"57","author":"G Brenta","year":"2013","unstructured":"Brenta, G. et al. Clinical practice guidelines for the management of hypothyroidism. Arq. Bras. Endocrinol. Metab. 57, 265\u2013291 (2013).","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"1203_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.clinbiochem.2008.01.014","volume":"41","author":"G Lippi","year":"2008","unstructured":"Lippi, G., Montagnana, M., Targher, G., Salvagno, G. L. & Guidi, G. C. Relationship between thyroid status and renal function in a general population of unselected outpatients. Clin. Biochem. 41, 625\u2013627 (2008).","journal-title":"Clin. Biochem."},{"key":"1203_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4158\/EP12282.OR","volume":"19","author":"Y Ye","year":"2013","unstructured":"Ye, Y., Gai, X., Xie, H., Jiao, L. & Zhang, S. Impact of thyroid function on serum cystatin C and estimated glomerular filtration rate: a cross-sectional study. Endocr. Pract. 19, 397\u2013403 (2013).","journal-title":"Endocr. Pract."},{"key":"1203_CR55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.maturitas.2013.03.009","volume":"75","author":"B Gopinath","year":"2013","unstructured":"Gopinath, B., Harris, D. C., Wall, J. R., Kifley, A. & Mitchell, P. Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas 75, 159\u2013164 (2013).","journal-title":"Maturitas"},{"key":"1203_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-10-0705","volume":"164","author":"BO Asvold","year":"2011","unstructured":"Asvold, B. O., Bjoro, T. & Vatten, L. J. Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Eur. J. Endocrinol. 164, 101\u2013105 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"1203_CR57","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10157-017-1400-2","volume":"21","author":"EJF Peixoto de Miranda","year":"2017","unstructured":"Peixoto de Miranda, E. J. F. et al. Thyrotropin levels are associated with chronic kidney disease among healthy subjects in cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clin. Exp. Nephrol. 21, 1035\u20131043 (2017). Among 13,193 participants in the Brazilian Longitudinal Study of Adult Health, subclinical hypothyroidism at baseline is statistically significantly associated with CKD (defined as GFR <60\u2009ml\/min\/1.73\u2009m2,\u00a0or GFR <60\u2009ml\/min\/1.73\u2009m2 and albuminuria).","journal-title":"Clin. Exp. Nephrol."},{"key":"1203_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19693-4","volume":"8","author":"YC Chang","year":"2018","unstructured":"Chang, Y. C., Chang, C. H., Yeh, Y. C., Chuang, L. M. & Tu, Y. K. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Sci. Rep. 8, 2031 (2018).","journal-title":"Sci. Rep."},{"key":"1203_CR59","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019569","volume":"99","author":"CW Huang","year":"2020","unstructured":"Huang, C. W. et al. Association between hypothyroidism and chronic kidney disease observed among an adult population 55 years and older. Medicine 99, e19569 (2020).","journal-title":"Medicine"},{"key":"1203_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03111-7","volume":"24","author":"HJ Kim","year":"2023","unstructured":"Kim, H. J. et al. Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study. BMC Nephrol. 24, 64 (2023).","journal-title":"BMC Nephrol."},{"key":"1203_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175763","volume":"12","author":"T Ittermann","year":"2023","unstructured":"Ittermann, T. et al. High thyroid-stimulating hormone and low free triiodothyronine levels are associated with chronic kidney disease in three population-based studies from Germany. J. Clin. Med. 12, 5763 (2023).","journal-title":"J. Clin. Med."},{"key":"1203_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1162626","volume":"14","author":"G Brenta","year":"2023","unstructured":"Brenta, G. et al. Low glomerular filtration rate values are associated with higher TSH in an elderly population at high cardiovascular disease risk. Front. Endocrinol. 14, 1162626 (2023).","journal-title":"Front. Endocrinol."},{"key":"1203_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105107","volume":"114","author":"Y Ma","year":"2023","unstructured":"Ma, Y., Shen, X., Yong, Z., Wei, L. & Zhao, W. Comparison of glomerular filtration rate estimating equations in older adults: a systematic review and meta-analysis. Arch. Gerontol. Geriatr. 114, 105107 (2023).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"1203_CR64","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1210\/jc.2013-3778","volume":"99","author":"CL Meuwese","year":"2014","unstructured":"Meuwese, C. L., Gussekloo, J., de Craen, A. J., Dekker, F. W. & den Elzen, W. P. Thyroid status and renal function in older persons in the general population. J. Clin. Endocrinol. Metab. 99, 2689\u20132696 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-8587(21)00285-0","volume":"10","author":"B Biondi","year":"2022","unstructured":"Biondi, B. & Cappola, A. R. Subclinical hypothyroidism in older individuals. Lancet Diabetes Endocrinol. 10, 129\u2013141 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1203_CR66","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/EJE-16-0537","volume":"175","author":"L Chaker","year":"2016","unstructured":"Chaker, L. et al. The association of thyroid function and the risk of kidney function decline: a population-based cohort study. Eur. J. Endocrinol. 175, 653\u2013660 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"1203_CR67","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/ndt\/gfw301","volume":"32","author":"UT Schultheiss","year":"2017","unstructured":"Schultheiss, U. T. et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities Study. Nephrol. Dial. Transpl. 32, 1874\u20131881 (2017). In this study of 4,600 patients, mainly with CKD stage 3 from the German Chronic Kidney Disease Study, hypothyroidism in 25% of the population leads to a 1.6 higher risk of the incident renal end point (combined ESRD, acute kidney injury and kidney-related death) after 4 years of follow-up.","journal-title":"Nephrol. Dial. Transpl."},{"key":"1203_CR68","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/ndt\/gfy071","volume":"34","author":"CL Meuwese","year":"2019","unstructured":"Meuwese, C. L. et al. Low thyroid function is not associated with an accelerated deterioration in renal function. Nephrol. Dial. Transpl. 34, 650\u2013659 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1203_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EC-19-0502","volume":"9","author":"LE Zijlstra","year":"2020","unstructured":"Zijlstra, L. E. et al. The kidney, subclinical thyroid disease and cardiovascular outcomes in older patients. Endocr. Connect. 9, 55\u201362 (2020).","journal-title":"Endocr. Connect."},{"key":"1203_CR70","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/ije\/dyu126","volume":"43","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int. J. Epidemiol. 43, 1624\u20131632 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"1203_CR71","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/jgs.14102","volume":"64","author":"MH Chuang","year":"2016","unstructured":"Chuang, M. H. et al. Abnormal thyroid-stimulating hormone and chronic kidney disease in elderly adults in Taipei City. J. Am. Geriatr. Soc. 64, 1267\u20131273 (2016).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1203_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/07435800.2019.1645164","volume":"45","author":"X Wang","year":"2020","unstructured":"Wang, X., Zhao, X. & Huang, X. Association of subclinical thyroid dysfunction with chronic kidney disease: a systematic review and meta-analysis. Endocr. Res. 45, 41\u201349 (2020).","journal-title":"Endocr. Res."},{"key":"1203_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000497326","volume":"142","author":"A Toda","year":"2019","unstructured":"Toda, A., Hara, S., Kato, M., Tsuji, H. & Arase, Y. Association of thyrotropin concentration with chronic kidney disease in a Japanese general population cohort. Nephron 142, 91\u201397 (2019).","journal-title":"Nephron"},{"key":"1203_CR74","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41440-023-01453-1","volume":"47","author":"K Endo","year":"2023","unstructured":"Endo, K. et al. A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort study. Hypertens. Res. 47, 663\u2013671 (2023).","journal-title":"Hypertens. Res."},{"key":"1203_CR75","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181","volume":"14","author":"JJ Carrero","year":"2018","unstructured":"Carrero, J. J., Hecking, M., Chesnaye, N. C. & Jager, K. J. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat. Rev. Nephrol. 14, 151\u2013164 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"1203_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-025-00228-9","volume":"18","author":"A Motaghedi Larijani","year":"2025","unstructured":"Motaghedi Larijani, A., Masoumi, S., Abdi, H., Amouzegar, A. & Azizi, F. The association of thyroid hormone levels and incidence of chronic kidney disease: the Tehran Thyroid Study (TTS). Thyroid. Res. 18, 13 (2025).","journal-title":"Thyroid. Res."},{"key":"1203_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mayocp.2023.08.028","volume":"99","author":"AS You","year":"2024","unstructured":"You, A. S. et al. Impact of thyroid status on incident kidney dysfunction and chronic kidney disease progression in a nationally representative cohort. Mayo Clin. Proc. 99, 39\u201356 (2024). In this longitudinal retrospective study of 4,152,830 patients, a higher risk of incident CKD or CKD progression is observed in patients with hypothyroidism (adjusted HR 1.70, 95% CI 1.59\u20131.83) and in those with subclinical hypothyroidism (HR 1.37, 95% CI 1.34\u20131.40).","journal-title":"Mayo Clin. Proc."},{"key":"1203_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-17-1-45","volume":"17","author":"EM Kaptein","year":"1996","unstructured":"Kaptein, E. M. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr. Rev. 17, 45\u201363 (1996).","journal-title":"Endocr. Rev."},{"key":"1203_CR79","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1172\/JCI108804","volume":"60","author":"VS Lim","year":"1977","unstructured":"Lim, V. S., Fang, V. S., Katz, A. I. & Refetoff, S. Thyroid dysfunction in chronic renal failure. A study of the pituitary\u2013thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J. Clin. Invest. 60, 522\u2013534 (1977).","journal-title":"J. Clin. Invest."},{"key":"1203_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2215\/CJN.12081111","volume":"7","author":"C Zoccali","year":"2012","unstructured":"Zoccali, C. & Mallamaci, F. Thyroid function and clinical outcomes in kidney failure. Clin. J. Am. Soc. Nephrol. 7, 12\u201314 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1203_CR81","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000166531","volume":"1","author":"EM Kaptein","year":"1981","unstructured":"Kaptein, E. M., Levitan, D., Feinstein, E. I., Nicoloff, J. T. & Massry, S. G. Alterations of thyroid hormone indices in acute renal failure and in acute critical illness with and without acute renal failure. Am. J. Nephrol. 1, 138\u2013143 (1981).","journal-title":"Am. J. Nephrol."},{"key":"1203_CR82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5301\/jn.5000106","volume":"26","author":"P Iglesias","year":"2013","unstructured":"Iglesias, P. et al. Thyroid function tests in acute kidney injury. J. Nephrol. 26, 164\u2013172 (2013).","journal-title":"J. Nephrol."},{"key":"1203_CR83","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12020-021-02640-1","volume":"73","author":"W Reinhardt","year":"2021","unstructured":"Reinhardt, W. et al. Association between albuminuria and thyroid function in patients with chronic kidney disease. Endocrine 73, 367\u2013373 (2021).","journal-title":"Endocrine"},{"key":"1203_CR84","first-page":"E641","volume":"260","author":"EM Kaptein","year":"1991","unstructured":"Kaptein, E. M., Hoopes, M. T., Parise, M. & Massry, S. G. rT3 metabolism in patients with nephrotic syndrome and normal GFR compared with normal subjects. Am. J. Physiol. 260, E641\u2013E650 (1991).","journal-title":"Am. J. Physiol."},{"key":"1203_CR85","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000381310","volume":"4","author":"S Benvenga","year":"2015","unstructured":"Benvenga, S., Vita, R., Di Bari, F., Fallahi, P. & Antonelli, A. Do not forget nephrotic syndrome as a cause of increased requirement of levothyroxine replacement therapy. Eur. Thyroid. J. 4, 138\u2013142 (2015).","journal-title":"Eur. Thyroid. J."},{"key":"1203_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijsu.2019.08.019","volume":"70","author":"H Xiong","year":"2019","unstructured":"Xiong, H. et al. A prognostic role for non-thyroidal illness syndrome in chronic renal failure:a systematic review and meta-analysis. Int. J. Surg. 70, 44\u201352 (2019).","journal-title":"Int. J. Surg."},{"key":"1203_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.850328","volume":"13","author":"S Sciacchitano","year":"2022","unstructured":"Sciacchitano, S. et al. Nonthyroidal illness syndrome: to treat or not to treat? Have we answered the question? A review of metanalyses. Front. Endocrinol. 13, 850328 (2022).","journal-title":"Front. Endocrinol."},{"key":"1203_CR88","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1172\/JCI109963","volume":"66","author":"VS Lim","year":"1980","unstructured":"Lim, V. S., Henriquez, C., Seo, H., Refetoff, S. & Martino, E. Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism. J. Clin. Invest. 66, 946\u2013954 (1980).","journal-title":"J. Clin. Invest."},{"key":"1203_CR89","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ki.1985.162","volume":"28","author":"VS Lim","year":"1985","unstructured":"Lim, V. S., Flanigan, M. J., Zavala, D. C. & Freeman, R. M. Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int. 28, 541\u2013549 (1985).","journal-title":"Kidney Int."},{"key":"1203_CR90","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s40620-016-0341-2","volume":"30","author":"W Yan","year":"2017","unstructured":"Yan, W., Wang, L. Huang, T. & Xu, G. Treatment for non-thyroidal illness syndrome in advanced chronic kidney disease: a single-blind controlled study. J. Nephrol. 30, 557\u2013565 (2017).","journal-title":"J. Nephrol."},{"key":"1203_CR91","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2215\/CJN.0000000000000487","volume":"19","author":"TY Yang","year":"2024","unstructured":"Yang, T. Y. et al. Sodium bicarbonate treatment and clinical outcomes in chronic kidney disease with metabolic acidosis: a meta-analysis. Clin. J. Am. Soc. Nephrol. 19, 959\u2013969 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1203_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010126","volume":"13","author":"A Mancini","year":"2024","unstructured":"Mancini, A. et al. Non-thyroidal illness in chronic renal failure: triiodothyronine levels and modulation of extra-cellular superoxide dismutase (ec-SOD). Antioxidants 13, 126 (2024).","journal-title":"Antioxidants"},{"key":"1203_CR93","volume":"11","author":"JM Colombijn","year":"2023","unstructured":"Colombijn, J. M. et al. Antioxidants for adults with chronic kidney disease. Cochrane Database Syst. Rev. 11, CD008176 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1203_CR94","volume":"37","author":"JM Chehade","year":"2024","unstructured":"Chehade, J. M. & Belal, H. F. Cross-section of thyroidology and nephrology: literature review and key points for clinicians. J. Clin. Transl. Endocrinol. 37, 100359 (2024).","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"1203_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-024-00201-y","volume":"17","author":"S Agahi","year":"2024","unstructured":"Agahi, S., Amouzegar, A., Honarvar, M., Azizi, F. & Mehran, L. Interrelationship between thyroid hormones and reduced renal function, a review article. Thyroid. Res. 17, 14 (2024).","journal-title":"Thyroid. Res."},{"key":"1203_CR96","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.2215\/CJN.00800208","volume":"3","author":"M Chonchol","year":"2008","unstructured":"Chonchol, M. et al. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1296\u20131300 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1203_CR97","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/0886022X.2020.1777162","volume":"42","author":"R Yuasa","year":"2020","unstructured":"Yuasa, R. et al. Prevalence of hypothyroidism in Japanese chronic kidney disease patients. Ren. Fail. 42, 572\u2013579 (2020).","journal-title":"Ren. Fail."},{"key":"1203_CR98","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2174\/0118715303268738231129093935","volume":"24","author":"W Xue","year":"2024","unstructured":"Xue, W. et al. Is kidney stone associated with thyroid disease? The United States National Health and Nutrition Examination Survey 2007-2018. Endocr. Metab. Immune Disord. Drug Targets 24, 1323\u20131334 (2024).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"1203_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00119","volume":"8","author":"D Santoro","year":"2017","unstructured":"Santoro, D., Vadala, C., Siligato, R., Buemi, M. & Benvenga, S. Autoimmune thyroiditis and glomerulopathies. Front. Endocrinol. 8, 119 (2017).","journal-title":"Front. Endocrinol."},{"key":"1203_CR100","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1681\/ASN.2015040373","volume":"27","author":"EL Yanik","year":"2016","unstructured":"Yanik, E. L., Clarke, C. A., Snyder, J. J., Pfeiffer, R. M. & Engels, E. A. Variation in cancer incidence among patients with ESRD during kidney function and nonfunction intervals. J. Am. Soc. Nephrol. 27, 1495\u20131504 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1203_CR101","doi-asserted-by":"publisher","first-page":"710","DOI":"10.21037\/gs-22-137","volume":"11","author":"L Hu","year":"2022","unstructured":"Hu, L., Wu, Y., Ju, F., Zhang, Y. & Wang, W. Effects of solid organ transplantation on the risk of developing thyroid cancer: a systematic review and meta-analysis. Gland. Surg. 11, 710\u2013719 (2022).","journal-title":"Gland. Surg."},{"key":"1203_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163530","volume":"10","author":"B Kim","year":"2021","unstructured":"Kim, B. et al. De novo cancer incidence after kidney transplantation in South Korea from 2002 to 2017. J. Clin. Med. 10, 3530 (2021).","journal-title":"J. Clin. Med."},{"key":"1203_CR103","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1677\/ERC-09-0191","volume":"17","author":"D Karamchandani","year":"2010","unstructured":"Karamchandani, D., Arias-Amaya, R., Donaldson, N., Gilbert, J. & Schulte, K. M. Thyroid cancer and renal transplantation: a meta-analysis. Endocr. Relat. Cancer 17, 159\u2013167 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"1203_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-018-0408-1","volume":"18","author":"M Veroux","year":"2019","unstructured":"Veroux, M. et al. Thyroid disease and cancer in kidney transplantation: a single-center analysis. BMC Surg. 18, 80 (2019).","journal-title":"BMC Surg."},{"key":"1203_CR105","first-page":"67","volume":"14","author":"E Yilmaz Akcay","year":"2016","unstructured":"Yilmaz Akcay, E. et al. Pretransplant thyroid findings in patients with end-stage renal disease. Exp. Clin. Transpl. 14, 67\u201370 (2016).","journal-title":"Exp. Clin. Transpl."},{"key":"1203_CR106","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/hdi.12527","volume":"21","author":"JC Lo","year":"2017","unstructured":"Lo, J. C. et al. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial. Int. 21, 534\u2013541 (2017).","journal-title":"Hemodial. Int."},{"key":"1203_CR107","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1210\/jc.2014-1850","volume":"99","author":"EM Kaptein","year":"2014","unstructured":"Kaptein, E. M., LoPresti, J. S. & Kaptein, M. J. Is an isolated TSH elevation in chronic nonthyroidal illness \u201csubclinical hypothyroidism\u201d? J. Clin. Endocrinol. Metab. 99, 4015\u20134026 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR108","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1523-1755.2005.00169.x","volume":"67","author":"JC Lo","year":"2005","unstructured":"Lo, J. C., Chertow, G. M., Go, A. S. & Hsu, C. Y. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 67, 1047\u20131052 (2005).","journal-title":"Kidney Int."},{"key":"1203_CR109","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.103750","volume":"19","author":"S Kazempour-Ardebili","year":"2021","unstructured":"Kazempour-Ardebili, S., Amouzegar, A., Tohidi, M., Amouzegar, A. & Azizi, F. Prevalence of subclinical hypothyroidism in chronic kidney disease in a population-based study: Tehran Thyroid Study. Int. J. Endocrinol. Metab. 19, e103750 (2021).","journal-title":"Int. J. Endocrinol. Metab."},{"key":"1203_CR110","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/ckj\/sfaa052","volume":"14","author":"UT Schultheiss","year":"2021","unstructured":"Schultheiss, U. T. et al. Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease Study. Clin. Kidney J. 14, 959\u2013968 (2021).","journal-title":"Clin. Kidney J."},{"key":"1203_CR111","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12020-021-02611-6","volume":"73","author":"S Tsuda","year":"2021","unstructured":"Tsuda, S. et al. Subclinical hypothyroidism is independently associated with poor renal outcomes in patients with chronic kidney disease. Endocrine 73, 141\u2013150 (2021).","journal-title":"Endocrine"},{"key":"1203_CR112","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/MNH.0000000000000542","volume":"28","author":"CM Rhee","year":"2019","unstructured":"Rhee, C. M. Thyroid disease in end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 28, 621\u2013630 (2019).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1203_CR113","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/jc.2014-4311","volume":"100","author":"CM Rhee","year":"2015","unstructured":"Rhee, C. M. et al. Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients. J. Clin. Endocrinol. Metab. 100, 1386\u20131395 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR114","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2016-3616","volume":"102","author":"CM Rhee","year":"2017","unstructured":"Rhee, C. M. et al. Thyroid status and mortality in a prospective hemodialysis cohort. J. Clin. Endocrinol. Metab. 102, 1568\u20131577 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR115","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1210\/jc.2016-1691","volume":"101","author":"CM Rhee","year":"2016","unstructured":"Rhee, C. M. et al. Thyroid functional disease and mortality in a national peritoneal dialysis cohort. J. Clin. Endocrinol. Metab. 101, 4054\u20134061 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR116","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/ndt\/gfy289","volume":"34","author":"AS You","year":"2019","unstructured":"You, A. S. et al. Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality. Nephrol. Dial. Transpl. 34, 2095\u20132104 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1203_CR117","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2012-1663","volume":"97","author":"DH Shin","year":"2012","unstructured":"Shin, D. H. et al. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 97, 2732\u20132740 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR118","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1185\/03007995.2015.1094044","volume":"31","author":"P Liu","year":"2015","unstructured":"Liu, P. et al. Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study. Curr. Med. Res. Opin. 31, 2233\u20132240 (2015).","journal-title":"Curr. Med. Res. Opin."},{"key":"1203_CR119","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11255-017-1756-y","volume":"50","author":"Y Chen","year":"2018","unstructured":"Chen, Y., Wu, G. & Xu, M. The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study. Int. Urol. Nephrol. 50, 97\u2013103 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"1203_CR120","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4158\/EP-2017-0017","volume":"24","author":"C Seo","year":"2018","unstructured":"Seo, C. et al. Thyroid hormone replacement reduces the risk of cardiovascular diseases in diabetic nephropathy patients with subclinical hypothyroidism. Endocr. Pract. 24, 265\u2013272 (2018).","journal-title":"Endocr. Pract."},{"key":"1203_CR121","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ekir.2020.10.016","volume":"6","author":"GN Blackaller","year":"2021","unstructured":"Blackaller, G. N. et al. A pilot trial on the effect of levothyroxine on proteinuria in patients with advanced CKD. Kidney Int. Rep. 6, 110\u2013119 (2021).","journal-title":"Kidney Int. Rep."},{"key":"1203_CR122","doi-asserted-by":"publisher","first-page":"e2446","DOI":"10.1210\/clinem\/dgae841","volume":"110","author":"Y Cheng","year":"2024","unstructured":"Cheng, Y. et al. Chronic kidney disease and thyroid hormones. J. Clin. Endocrinol. Metab. 110, e2446\u2013e2455 (2024). This study investigates the therapeutic effects of thyroid hormone replacement therapy (THRT) in patients with CKD in a retrospective cohort study using data from the China Renal Data System. THRT is associated with a significantly reduced risk of renal failure (adjusted HR 0.65, 95% CI 0.52\u20130.82; P<0.001) in patients with hypothyroidism.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR123","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mayocp.2018.01.024","volume":"93","author":"CM Rhee","year":"2018","unstructured":"Rhee, C. M. et al. Thyroid status and death risk in US veterans with chronic kidney disease. Mayo Clin. Proc. 93, 573\u2013585 (2018). In this study of 227,422 US veterans with stage 3 non-dialysis-dependent CKD, TSH levels >5.0\u2009mU\/l are associated with higher mortality. In time-dependent analyses, untreated and under-treated hypothyroidism are associated with higher mortality, whereas hypothyroidism treated-to-target is associated with lower mortality.","journal-title":"Mayo Clin. Proc."},{"key":"1203_CR124","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s12325-020-01589-3","volume":"38","author":"JV Hennessey","year":"2021","unstructured":"Hennessey, J. V., Weir, M. R., Soni-Brahmbhatt, S., Duan, Y. & Gossain, V. V. Effect of levothyroxine on kidney function in chronic kidney disease with subclinical hypothyroidism in US veterans: a retrospective observational cohort study. Adv. Ther. 38, 1185\u20131201 (2021).","journal-title":"Adv. Ther."},{"key":"1203_CR125","doi-asserted-by":"publisher","first-page":"E744","DOI":"10.1503\/cmaj.250356","volume":"197","author":"OHY Yu","year":"2025","unstructured":"Yu, O. H. Y. et al. Levothyroxine treatment for subclinical hypothyroidism and risk of adverse renal outcomes: a population-based cohort study. CMAJ 197, E744\u2013E753 (2025).","journal-title":"CMAJ"},{"key":"1203_CR126","first-page":"282","volume":"109","author":"DS Silverberg","year":"1973","unstructured":"Silverberg, D. S. et al. Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can. Med. Assoc. J. 109, 282\u2013286 (1973).","journal-title":"Can. Med. Assoc. J."},{"key":"1203_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-0947-9","volume":"19","author":"E Cataldo","year":"2018","unstructured":"Cataldo, E. et al. Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature. BMC Nephrol. 19, 155 (2018).","journal-title":"BMC Nephrol."},{"key":"1203_CR128","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1210\/clinem\/dgad483","volume":"109","author":"T Haraguchi","year":"2023","unstructured":"Haraguchi, T. et al. Effect of roxadustat on thyroid function in patients with renal anemia. J. Clin. Endocrinol. Metab. 109, e69\u2013e75 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1203_CR129","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/clinchem\/hvab278","volume":"68","author":"WG Miller","year":"2022","unstructured":"Miller, W. G. et al. National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories. Clin. Chem. 68, 511\u2013520 (2022).","journal-title":"Clin. Chem."},{"key":"1203_CR130","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/jalm\/jfad022","volume":"8","author":"CC Pierre","year":"2023","unstructured":"Pierre, C. C. et al. AACC\/NKF guidance document on improving equity in chronic kidney disease care. J. Appl. Lab. Med. 8, 789\u2013816 (2023).","journal-title":"J. Appl. Lab. Med."},{"key":"1203_CR131","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1046\/j.1523-1755.2003.00181.x","volume":"64","author":"R Schmitt","year":"2003","unstructured":"Schmitt, R. & Bachmann, S. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 64, 1139\u20131140 (2003).","journal-title":"Kidney Int."},{"key":"1203_CR132","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"1203_CR133","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","unstructured":"The EMPA-KIDNEY Collaborative Group Empagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 388, 117\u2013127 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1203_CR134","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 383, 1436\u20131446 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1203_CR135","volume":"5","author":"P Natale","year":"2024","unstructured":"Natale, P. et al. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes. Cochrane Database Syst. Rev. 5, CD015588 (2024).","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01203-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01203-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01203-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:01:42Z","timestamp":1773709302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01203-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01203-y","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"17 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}